ART fees too high: HIV, Aids Stakeholders
STAKEHOLDERS in the HIV and Aids sector have complained over “deterrent” Antiretroviral Treatment (ART) user fees saying they are discouraging efforts to contain the disease. In Zimbabwe, ART is over ...
Read more